CompletedPhase 3

Shivering Control After Percutaneous Nephrolithotomy

Egypt80 participantsStarted 2021-01-03

Plain-language summary

Aim of the study is comparing the effect of amino acid versus magnesium sulfate infusion on postoperative shivering in patients undergoing elective percutaneous nephrolithotomy surgery under general anesthesia.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * ASA I-II who were listed for elective percutaneous nephrolithotomy PCNL surgery under general anesthesia. Exclusion Criteria: * Hepatic inefficiency * Renal inefficiency * Spinal anesthesia because of a different mechanism of hypothermia

What they're measuring

Postoperative shivering grade

Timeframe: 2 hours postoperative

Trial details

NCT IDNCT04695613

SponsorAssiut University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-03-25

View on ClinicalTrials.gov More Shivering Control trials